JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UNIT
2951
PUT
Uniti Group
UNIT
$1.99B
| $2.92M | ﹤0.01% |
164,400
+97,200
| +145% | +$1.6M |
2017 Q3
1 quarter
|
|
2952
Four Corners Property Trust
FCPT
$2.38B
| $2.9M | ﹤0.01% |
112,952
+58,473
| +107% | +$1.5M |
2015 Q4
8 quarters
|
|
2953
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.07B
| $2.9M | ﹤0.01% |
36,114
-10,970
| -23% | -$882K |
2015 Q4
8 quarters
|
|
|
HOME
2954
DELISTED
At Home Group Inc.
HOME
| $2.89M | ﹤0.01% |
+95,059
| New | +$2.31M |
2017 Q4
0 quarters
|
|
2955
Peoples Bancorp
PEBO
$1.35B
| $2.88M | ﹤0.01% |
88,343
-857
| -1% | -$28.6K |
2016 Q4
4 quarters
|
|
2956
CALL
Snap
SNAP
$9.59B
| $2.88M | ﹤0.01% |
+197,200
| New | +$2.87M |
2017 Q4
0 quarters
|
|
|
GUDB
2957
DELISTED
Sage ESG Intermediate Credit ETF
GUDB
| $2.88M | ﹤0.01% |
+57,988
| New | +$2.89M |
2017 Q4
0 quarters
|
|
2958
American Public Education
APEI
$798M
| $2.88M | ﹤0.01% |
114,918
-901
| -0.8% | -$21K |
2016 Q2
6 quarters
|
|
2959
Karyopharm Therapeutics
KPTI
$18.6M
| $2.87M | ﹤0.01% |
19,953
-527
| -3% | -$84.6K |
2013 Q4
16 quarters
|
|
|
ESV
2960
DELISTED
Ensco Rowan plc
ESV
| $2.87M | ﹤0.01% |
121,382
-20,336
| -14% | -$451K |
2013 Q2
18 quarters
|
|
2961
CALL
Whirlpool
WHR
$1.98B
| $2.87M | ﹤0.01% |
+17,000
| New | +$2.88M |
2017 Q4
0 quarters
|
|
|
2962
PUT
Whirlpool
WHR
$1.98B
| $2.87M | ﹤0.01% |
+17,000
| New | +$2.88M |
2017 Q4
0 quarters
|
|
|
ATRI
2963
DELISTED
Atrion Corp
ATRI
| $2.86M | ﹤0.01% |
4,536
+479
| +12% | +$313K |
2016 Q3
5 quarters
|
|
|
MGI
2964
DELISTED
MoneyGram International, Inc. New
MGI
| $2.86M | ﹤0.01% |
216,903
-203,293
| -48% | -$2.97M |
2014 Q2
14 quarters
|
|
2965
National Bank Holdings
NBHC
$1.71B
| $2.85M | ﹤0.01% |
87,959
+27,328
| +45% | +$910K |
2013 Q2
18 quarters
|
|
2966
TriMas Corp
TRS
$1.41B
| $2.83M | ﹤0.01% |
105,818
-18,858
| -15% | -$502K |
2013 Q2
18 quarters
|
|
2967
Travere Therapeutics
TVTX
$5.34B
| $2.83M | ﹤0.01% |
134,237
+2,105
| +2% | +$48.1K |
2016 Q4
4 quarters
|
|
2968
PUT
Lockheed Martin
LMT
$117B
| $2.83M | ﹤0.01% |
8,800
+7,000
| +389% | +$2.21M |
2016 Q4
4 quarters
|
|
|
ONIT
2969
CALL
Onity Group
ONIT
$229M
| $2.82M | ﹤0.01% |
60,000
| – | – |
2016 Q2
6 quarters
|
|
2970
Safety Insurance
SAFT
$1.53B
| $2.81M | ﹤0.01% |
35,012
-1,977
| -5% | -$160K |
2016 Q1
7 quarters
|
|
2971
PUT
Cleveland-Cliffs
CLF
$6.54B
| $2.81M | ﹤0.01% |
390,000
+239,700
| +159% | +$1.59M |
2016 Q4
4 quarters
|
|
2972
Warner Bros
WBD
$77.6B
| $2.81M | ﹤0.01% |
125,554
+75,579
| +151% | +$1.48M |
2013 Q2
18 quarters
|
|
|
BRKL
2973
DELISTED
Brookline Bancorp
BRKL
| $2.81M | ﹤0.01% |
178,736
-77,899
| -30% | -$1.21M |
2015 Q2
10 quarters
|
|
2974
Central Garden & Pet Co
CENT
$2.48B
| $2.8M | ﹤0.01% |
89,871
+24,977
| +38% | +$765K |
2015 Q4
8 quarters
|
|
2975
CALL
Nokia
NOK
$59.5B
| $2.8M | ﹤0.01% |
+600,000
| New | +$3.09M |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.